Active broad-market exchange-traded funds in Friday's regular session:
SPDR S&P 500 ( SPY ): -0.33%
iPath S&P 500 VIX ST Futures ETN ( VXX ): +3.43%
iShares MSCI Emerging Markets Index ( EEM ): -0.38%
iShares Russell 2000 Index ( IWM ): -0.89%
PowerShares QQQ Trust, Series ( QQQ ): -0.02%
Broad Market Indicators
Broad-market exchange-traded funds, including SPY, IWM and IVV are higher pre-market. Likewise, actively traded PowerShares QQQ ( QQQ ) rose 0.5%. Direxion Daily Russian Bull 3X (RUSL) was higher as Ukraine and Russia discussed a possible truce.
U.S. stock futures are pointing to a higher open amid merger and acquisition activity and as the Ukraine/ Russia talks eased geopolitical tensions. Family Dollar Corp. (FDO) surged 7.9% in early New York trading after offering $9.7 billion for Family Dollar Stores Inc.
Power Play: Technology
Technology Select Sector SPDR ETF (XLK) was up 0.4%, while iShares Dow Jones US Technology ETF (IYW), iShares S&P North American Technology ETF (IGM) and iShares S&P North American Technology-Software Index (IGV) were inactive after closing mixed Friday. SPDR S&P International Technology Sector ETF (IPK) was flat.
Among semiconductor ETFs, SPDR S&P Semiconductor (XSD) and Semiconductor Sector Index Fund (SOXX) are unchanged after a higher close Friday. Direxion Daily Semiconductor Bear 3X (SOXS) is up 12% and is the best-performing ETF pre-bell Monday.
Sky-mobi (MOBI) shares jumped 16% after the company reported Q2 revenues that increased over Q2 2013, fueled by growth from the smartphone business. The China-based mobile application developer reported Q2 earnings per ADS of $0.04 and total revenues of US$27.4 million, or RMB170.2 million, an increase from RMB125.2 million in the prior year period. Analyst estimates were not available.
Winners and Losers
Consumer Staples Select Sector SPDR (XLP), iShares Dow Jones US Consumer Goods (IYK), and Vanguard Consumer Staples ETF (VDC) are all unchanged pre-market after closing higher on Friday.
Family Dollar Stores (FDO) shares rose in Monday's pre-market session after the dollar-store operator received an offer to be bought by larger rival Dollar General (DG) for $78.50 per share in cash, topping Dollar Tree's (DLTR) bid last month to buy Family Dollar for $74.50 per share in cash and stock.
Dollar General's shares also rose pre-market on the bid, which would value Family Dollar at about $9.7 billion. FDO was up 5.2% at $80.02 in recent pre-market trading , putting it on track for a fresh record high above its current regular-session high of $79.93. Meanwhile, DG climbed 10% to $63.35, nearing its all-time high of $65.99.
Select Financial Sector SPDRs (XLF) is unchanged. Direxion Daily Financial Bull 3X shares (FAS) is up 1.1% pre-bell, while its bearish counterpart, FAZ, was inactive.
Financial services provider China Finance Online (JRJC) Monday announced the launch of China's first independent web-based securities trading platform, Securities Master, on the financial portals it operates, www.jrj.com and www.stockstar.com. JRJC American Depositary Receipts rose 5% in recent pre-market trading on Monday after closing at $4.45 on Friday.
Dow Jones U.S. Energy Fund (IYE) and Energy Select Sector SPDR (XLE) are unchanged after a stronger close Friday.
Apache (APA), a natural gas and crude oil company, has made one of Australia's largest oil discoveries in decades after an exploration well found as much as 300 million crude barrels of offshore oil, the Wall Street Journal reports.
APA shares are up more than 2% pre-market and trade in a 52-week range of $75.07 to $104.57, with shares having closed up 0.76% at $98.68 Friday.
Crude was down 0.8%; United States Oil Fund (USO) was down 0.48%. Natural gas fell 0.26% and United States Natural Gas Fund (UNG) was down 0.77%.
Gold was down 0.3%, and silver was up 0.2%. Among rare metal funds, SPDR Gold Trust (GLD) was down 0.3% and iShares Silver Trust (SLV) was also down 0.3%.
Health Care SPDR (XLV), iShares Dow Jones US Healthcare (IYH) and Vanguard Health Care ETF (VHT) are inactive after recovering to close slightly firmer Friday. Biotech ETF iShares NASDAQ Biotechnology Index (IBB) was up 0.6%.
Achillion Pharmaceuticals (ACHN) shares are up almost 6% pre-market after the company on Friday said patients treated with its ACH-3102 drug candidate for hepatitis C showed no signs of the virus after four weeks during Phase II testing.
According to the company, all 12 patients taking the drug when combined with Gilead Sciences (GILD) Sovaldi Hep C treatment showed no detectable traces of the virus after four weeks. ACHN now plans to begin trials with 12 additional patients for six weeks with a once-daily dose of the two drugs.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.